Status:
COMPLETED
Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
JW Pharmaceutical
Conditions:
Gastric Cancer
Colon Cancer
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Patients who underwent major gastrointestinal surgery is potentially at risk of malnutrition due to reduced oral intake, increased nutritional need, reduced gastrointestinal absorption function, and/o...
Eligibility Criteria
Inclusion
- Male or female who are 20 or more years old and not more than 80 years old
- Discharge from a hospital is planned within 2 weeks after major gastrointestinal surgery (except when ileostomy is performed)
- oral intake is possible at the time of discharge
- no preoperative chemotherapy or preoperative radiotherapy
- voluntarily agreed with the informed consent of this clinical trial
Exclusion
- Intravenous or other specific nutritional treatment is needed
- BMI \>25 and postoperative weight loss is not \> 5% of preoperative body weight at the time of discharge
- Allergy to milk, whey, bean, salmon, or the investigational product
- Residual of cancer in the abdominal cavity postoperatively if it is cancer case
- Presence of synchronous other cancers that needs treatment.
- When investigator judged that the patient is not eligible to the trial
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT01838109
Start Date
April 1 2013
End Date
April 1 2014
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea